IL6 and colorectal cancer: For example, decreased expression of miR155-5p has been shown to increase the expression of C/EBPβ and IL6 in TAMs, which in turn leads to activation of the IL6R/STAT3/miR-204-5p pathway and induction of chemoresistance in colorectal cancer cells [238].